NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Mapping large numbers of results may take a few moments.

Search Results

Showing 251 - 300 of 340 results found.

Activity Company Description Location
Company Praetego Inc. Activity: Research and Development Research and Development Company Description Praetego is preclinical stage pharmaceutical company committed to improving health outcomes by addressing chronic diseases of aging, starting with Alzheimer’s Disease. Praetego’s novel small molecules inhibit a systemic driver of oxidative stress at the initiation of pathology. Location Research Triangle Park
Company Precise Bio Inc. Activity: Research and Development Research and Development Company Description Precise Bio grows live and vital complicated organs for transplant using 3D bio-printing. Location Winston-Salem
Company Priovant Therapeutics Activity: Research and Development Research and Development Company Description Priovant is developing and commercializing targeted therapeutics for patients with severe autoimmune disease. Location Durham
Company Pruvyc Pharma LLC Activity: Research and Development Research and Development Company Description Pruvyc Pharma is developing a method for treating pruritus. Location Cary
Company Qatch Technologies LLC Activity: Research and Development Research and Development Company Description QATCH develops a microfluidic viscometer that screens injectability and manufacturability of biopharmaceutical formulations in preclinical drug development. Location Durham
Company QuatroBio LLC Activity: Research and Development Research and Development Company Description QuatroBio provides oversight and strategic direction to several closely held drug development companies. Location Morrisville
Company Qura Therapeutics LLC Activity: Research and Development Research and Development Company Description Qura Therapeutics is discovering therapeutics for curing HIV/AIDS. Qura is a joint venture between ViV Healthcare and UNC-CH and provides financial, material and development support for therapies that emerge from research at the UNC HIV Cure Center. Location Chapel Hill
Company RainBio Inc. Activity: Research and Development Research and Development Company Description RainBio is developing AAV (adeno-associated virus) gene therapy corneal treatments to address the unmet need of treatment of rare corneal blinding diseases. Location Raleigh
Company READDI Inc. Activity: Research and Development Research and Development Company Description Rapidly Emerging Antiviral Drug Development Initiative (READDI) is a public-private partnership that develops broad-spectrum antiviral therapies for COVID-19 and other emerging viral threats. Location Chapel Hill
Company Regennova Inc. Activity: Research and Development Research and Development Company Description Regennova develops therapeutics for inflammatory diseases and neurological disorders, including cerebral stroke, traumatic brain injury, Alzheimer's and sepsis. Location Durham
Company Relevant Biosciences Inc. Activity: Research and Development Research and Development Company Description Relevant Bio develops natural antibody-based cancer therapeutics. Location Raleigh
Company Renew Design Inc. Activity: Research and Development Research and Development Company Description Renew Design transforms domestic and international agricultural waste into marketable products. Location Winston-Salem
Company Renovion Inc. Activity: Research and Development Research and Development Company Description Renovion is a clinical stage company developing therapies for chronic inflammatory lung diseases, including bronchiectasis, BOS in lung transplant and chronic bronchitis. Location Chapel Hill
Company Reselute Inc. Activity: Research and Development Research and Development Company Description Reselute is developing a medical device for the treatment of orthopedic implant related infections. Location Durham
Company Resilient Biotics Inc. Activity: Research and Development Research and Development Company Description Resilient Biotics is developing non-antibiotic, microbiome-based therapeutics to combat complex respiratory infections with applications in human and animal health. Resilient utilizes a proprietary discovery platform for product development and has a broad pipeline across multiple species. Location Durham
Company Resonantia Diagnostics Activity: Research and Development Research and Development Company Description Resonantia Diagnostics is a startup developing a point of care diagnostic platform that rapidly identifies a pathogen from a clinical specimen and determines the pathogen's antimicrobial susceptibility. Location Durham
Company Reveris Therapeutics LLC Activity: Research and Development Research and Development Company Description Reveris Therapeutics develops novel therapeutics for triple negative breast cancer (TNBC). Location Chapel Hill
Company Revivo Therapeutics Inc. Activity: Research and Development Research and Development Company Description Revivo Therapeutics is a clinical stage company developing therapies for cognitive dysfunction and neuroprotection. Location Durham
Company Rilento Pharma LLC Activity: Research and Development Research and Development Company Description Rilento Pharma is a preclinical stage drug delivery company developing non-addictive oral surgery pain management technologies that are synchronized with the biologic process of wound healing. Location Raleigh
Company Roke Biotechnologies LLC Activity: Research and Development Research and Development Company Description Roke Biotechnologies develops novel 2-stage protein expression and purification technologies for making proteins used in research and in the industrial and pharmaceutical industries. Location Durham
Company RT Cardiac Systems Inc. Activity: Research and Development Research and Development Company Description RT Cardiac Systems is developing a proprietary blood pump technology for acute circulatory support to improve and advance therapy for high-risk percutaneous coronary intervention (HR PCI) and emergent heart failure. Location Raleigh
Company RTT Medical Activity: Research and Development Research and Development Company Description RTT Medical provides regenerative tissue technologies for wound management. Location Winston-Salem
Company Sapere Bio Inc. Activity: Research and Development Research and Development Company Description Sapere Bio develops biomarkers of aging for clinical use to help physicians predict risk of chemotherapy-induced toxicities and surgery-associated adverse events in various patient groups. Location Research Triangle Park
Company Sarepta Therapeutics Inc. (Durham) Activity: Research and Development Research and Development Company Description Sarepta Therapeutics develops precision genetic medicine treatments for Duchenne muscular dystrophy (DMD), Limb-girdle muscular dystrophy (LGMD) and other central nervous system (CNS) disorders. Sarepta's Gene Editing Innovation Center is in Durham. Location Durham
Company Satsuma Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description Satsuma Pharmaceuticals is developing best-in-class intranasal drug products to address the significant unmet medical needs of acute migraine sufferers. Location Durham
Company Scientific Purity LLC Activity: Research and Development Research and Development Company Description Scientific Purity is developing more nutritious plants for consumers. Location Bunn
Company SelSym Biotech Inc. Activity: Research and Development Research and Development Company Description SeySym Biotech develops novel biomimetic materials for treating hemorrhage following trauma and surgery. Location Durham
Company Shear Induced Technologies Activity: Research and Development Research and Development Company Description ShearIT is developing and commercializing Lamiflo, a non-pharmacologic treatment for cerebrovascular disease. Location Lewisville
Company SIF Biopharma LLC Activity: Research and Development Research and Development Company Description SIF Biopharma develops new therapies in the areas of regenerative medicine and cancer. Location Chapel Hill
Company SiNON Nano Sciences Inc. Activity: Research and Development Research and Development Company Description SiNON is developing technology to treat neurological diseases by increasing the ability of drugs to cross the blood brain barrier (BBB). Location Durham
Company Sirtsei Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description Sirtsei Pharmaceuticals is developing a product for depression and schizophrenia. Location Morrisville
Company Soil Health Institute Activity: Research and Development Research and Development Company Description The Soil Health Institute partners with stakeholders to safeguard and enhance the vitality and productivity of soil through scientific research and advancement. Location Morrisville
Company Solve Therapeutics Inc. Activity: Research and Development Research and Development Company Description Solve Therapeutics develops antibody-drug conjugates (ADC) and antibody-radionuclide conjugates (ARC) for oncology patients. Location Durham
Company Sonokine Bioscience Inc. Activity: Research and Development Research and Development Company Description Sonokine Biosciences is developing cancer treatments that use high intensity focused ultrasound in combination with targeted delivery of immune therapies. Location Chapel Hill
Company SonoVascular Inc. Activity: Research and Development Research and Development Company Description SonoVascular has developed a novel pharmaco-mechanical ultrasound facilitated thrombectomy system that utilizes microbubble-mediated cavitation as a core enabling mechanism of action to more effectively treat deep vein thrombosis and pulmonary embolism. Location Chapel Hill
Company SonoVol Inc Activity: Research and Development Research and Development Company Description SonoVol has developed a preclinical imaging technology that can be applied to in vivo models that researchers use to evaluate the efficacy and toxicity of new drugs before they enter clinical trials. Location Durham
Company SP Innovations LLC Activity: Research and Development Research and Development Company Description SP Innovations is developing a graft for irreparable rotator cuff tendon injuries. Location Raleigh
Company Sparta Biomedical Inc. Activity: Research and Development Research and Development Company Description Sparta Biomedical is developing cartilage-like implants to mimic the properties of native cartilage and address degeneration in joints. Location Morrisville
Company Speedwell Bio LLC Activity: Research and Development Research and Development Company Description Speedwell Bio develops novel molecular assays and reagents for research and clinical diagnostics. Location Chapel Hill
Company SpringWorks Therapeutics LLC Activity: Research and Development Research and Development Company Description SpringWorks Therapeutics develops standalone and combination therapies with a focus on rare diseases and oncology, including plexiform neurofibroma, desmoid tumors, RAS/RAF mutant solid tumors and CNS disorders. Its initial portfolio is from Pfizer. Location Durham
Company SPV Therapeutics Inc. Activity: Research and Development Research and Development Company Description SPV Therapeutics is developing small molecule therapeutics to treat cancer. Location Research Triangle Park
Company Sustainable Agriculture Labs Activity: Research and Development Research and Development Company Description Sustainable Agriculture Labs develops specialty crops via plant biotechnology methods. Location Raleigh
Company Symberix Inc. Activity: Research and Development Research and Development Company Description Symberix is developing microbiome-targeted, small-molecule drugs to treat serious lower gastrointestinal (GI) diseases such as Inflammatory Bowel Disorder (IBD) as well as mitigate the lower GI side effects associated with various pain, cancer and immunosuppressive therapies. Location Durham
Company Synoxa Sciences Inc. Activity: Research and Development Research and Development Company Description Synoxa Sciences develops small molecule therapeutics to treat multi-drug resistant (MDR) bacterial pathogens, including those in the biofilm state. Location Raleigh
Company T3D Therapeutics Inc. Activity: Research and Development Research and Development Company Description T3D Therapeutics is developing a disease-modifying drug therapy for Alzheimer’s disease that may improve multiple disease defects. T3D is also targeting treatments for other neurodegenerative diseases including Huntington's Disease. Location Research Triangle Park
Company Tavros Therapeutics Inc. Activity: Research and Development Research and Development Company Description Tavros is developing first-in-class therapeutics for cancer by using a novel precision oncology platform. Location Research Triangle Park
Company TCRCure Biopharma Corp. Activity: Research and Development Research and Development Company Description TCRCure Biopharma discovers and develops novel therapeutic targets in the field of cancer immunotherapy. Location Durham
Company Techverse Inc. Activity: Research and Development Research and Development Company Description Techverse provides contract chemistry and engineering R&D services for advanced energy technologies. Expertise includes membrane technologies for biotechnology applications; algae separation; and hydrogen generation, separation, storage and fuel cells. Location Cary
Company Tellus Therapeutics Inc. Activity: Research and Development Research and Development Company Description Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. Location Research Triangle Park
Company Ten63 Therapeutics Inc. Activity: Research and Development Research and Development Company Description Ten63 Therapeutics uses computational chemistry and AI to screen trillions of molecules to discover new therapeutics for a wide variety of diseases. Location Durham